Predictors of COVID-19 vaccine uptake among people who use substances: a case study in Tehran.
Karimi SE, Amadi S, Rampisheh Z, Tayefi B, Soleimanvandiazar N, Higgs P, Tehrani-Banihashemi A, Hajebi A, Nojomi M, Karimijavan G
COVID-19 Injecting Drug Use
Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States.
Toumi M, Wallace J, Cohen C, Marshall C, Kitchen H, Macey J, Pegram H, Slagle AF, Gish RG, Ning Q, Yatsuhashi H, Cornberg M, Brunetto M, van Bömmel F, Xie Q, Lee D, Habuka N, Sbarigia U, Beumont-Mauviel M, Keever AV, Takahashi Y, Lu Y, Liu A, Chen Q, Ito T, Radunz O, Puggina A, Hilgard G, Chan EKH, Wang S
Hepatitis B
Youth drinking in decline: Recent developments and future priorities.
Livingston M, Taylor N, Raninen J, Pennay A
Alcohol and Other Drugs Young People's Health
"No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
Walker S, Curtis M, Kirwan A, Thatcher R, Dietze P
Injecting Drug Use
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019.
Requena MB, Protopopescu C, Stewart AC, van Santen DK, Klein MB, Jarrin I, Berenguer J, Wittkop L, Salmon D, Rauch A, Prins M, van der Valk M, Sacks-Davis R, Hellard ME, Carrieri P, Lacombe K; on behalf of the InCHEHC Collaboration
HIV + AIDS Hepatitis C Global Infectious Disease Threats
High SARS-CoV-2 attack rates in areas with low detection after community transmission established in Port Vila, Vanuatu, April 2022.
Toa F, Williams W, Yapa C, Cornish M, Binihi M, van Gemert C
COVID-19